ZTS Q4 2022 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$54B

Q4 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.0B+3.7% YoY

Gross Profit

$1.4B66.3% margin

Operating Income

$690M33.8% margin

Net Income

$461M22.6% margin

EPS (Diluted)

$0.99

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

$741M

Free Cash Flow

$570M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$14.9B

Total Liabilities

$10.5B

Stockholders' Equity

$4.4B

Cash & Equivalents

$3.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.0B	$2.0B	+3.7%
Gross Profit	$1.4B	$1.3B	+1.9%
Operating Income	$690M	$596M	+15.8%
Net Income	$461M	$414M	+11.4%

Revenue Segments

Horses

$4.8B87%

Cattle

$377M7%

Swine

$138M3%

Poultry

$115M2%

Fish

$61M1%

Geographic Segments

United States Segment

$1.1B55%

International Segment

$901M45%